Freelite
Commercial- Indications
- Multiple Myeloma, MGUS
Company intelligence / Profile preview
The Binding Site
Birmingham, United Kingdomthermofisher.com ↗
- Ownership
- Private
- Employees
- ~1100
- Development stage
- Commercial
01
Overview
The Binding Site’s diagnostic products—especially Freelite®—are globally recognized as the gold standard for diagnosis and monitoring of multiple myeloma. Their tests are recommended by major clinical guidelines (IMWG) for all stages of disease management. They have a strong track record of innovation in specialty protein diagnostics with over 4,300 supporting publications. Their business has grown at ~10% annually with revenues exceeding $220 million in 2022 prior to acquisition by Thermo Fisher Scientific
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Diagnostic assay (Immunoassay)Protein analysis instrumentation
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on The Binding Site.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The Binding Site.